Pharma/Life Sciences: Corporate | France

Alain Decombe maintains an eminent reputation for his advice on corporate transactions in the life sciences sector. He is adept at assisting with cross-border mandates.

Emmanuelle Trombe is widely recognised as a leading corporate practitioner in the pharmaceutical and life sciences sectors, with outstanding expertise in acquisitions, financing rounds and licensing agreements

Jean-Marc Grosperrin boasts a leading corporate practice, advising pharmaceutical companies on commercial agreements and acquisitions.

Anthony Paronneau boasts experience in M&A transactions and licensing matters. He is highly sought after by biotech startups.

Emmanuelle Porte handles a range of corporate matters in the pharmaceutical sector, including acquisitions and fundraisings.

Gilles Bigot boasts longstanding experience advising on transactional matters, including primary LBOs. He also assists healthcare clients with structuring and partnership mandates.

Sonia de Kondserovsky assists pharmaceutical companies with cross-border acquisitions and investments.

Anne-Charlotte Rivière advises clients on corporate matters in the life science space, offering notable experience in venture capital and M&A transactions.

Anne-France Moreau handles M&A mandates in the pharmaceutical sector, including private equity transactions.

Julie Vern Cesano-Gouffrant advises pharmaceutical and medical devices companies on M&A and corporate matters.

Julien Le Guyader is recognised for his handling of asset and rights acquisition as well as regulatory matters. He advises both French and international pharmaceutical clients.

Renaud Bonnet is highly recognised for assisting technology and life sciences companies with a range of corporate transactions, including financing rounds and initial public offerings.